Engineered fat cells starve tumors and prevent cancer growth

Scientists transformed energy-storing white fat cells into calorie-burning ‘beige’ fat. Once implanted, they outcompeted tumors for resources, beating back five different types of cancer in lab experiments.

Opinion | The Cancer Journey Is Not Unique to the Royals

Saldanha is a Chief Innovation Officer. Phull is an oncologist and physician scientist. The royal family in the U.K. has had a rough start to

March 30, 2024

Pharmalittle: We’re reading about slow uptake of an Alzheimer’s drug, an opioid lawsuit, and more

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After

February 14, 2024

FDA is poised to pull Ocaliva as adcomm documents question post-approval study results

The FDA appeared ready to pull its accelerated approval of Alfasigma and Intercept Pharmaceuticals’ rare liver disease drug Ocaliva, bluntly laying out its rationale in

September 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.